Donald L. Hagan LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $927K | Buy |
+20,550
| New | +$960K | 0.46% | 53 |
|
|
2023
Q4 | – | Sell |
-23,378
| Closed | -$1.36M | – | 101 |
|
|
2023
Q3 | $1.36M | Sell |
23,378
-2,586
| -10% | -$158K | 0.81% | 22 |
|
|
2023
Q2 | $1.66M | Sell |
25,964
-791
| -3% | -$53K | 0.94% | 17 |
|
|
2023
Q1 | $1.85M | Buy |
26,755
+4,890
| +22% | +$345K | 1.02% | 14 |
|
|
2022
Q4 | $1.57M | Buy |
21,865
+1,472
| +7% | +$111K | 0.99% | 21 |
|
|
2022
Q3 | $1.45M | Buy |
20,393
+442
| +2% | +$32.1K | 1.03% | 13 |
|
|
2022
Q2 | $1.54M | Sell |
19,951
-987
| -5% | -$75.2K | 0.98% | 18 |
|
|
2022
Q1 | $1.53M | Buy |
20,938
+484
| +2% | +$32.5K | 0.86% | 22 |
|
|
2021
Q4 | $1.27M | Buy |
20,454
+15,478
| +311% | +$908K | 0.66% | 28 |
|
|
2021
Q3 | $294K | Buy |
4,976
+647
| +15% | +$42.6K | 0.17% | 91 |
|
|
2021
Q2 | $289K | Hold |
4,329
| – | – | 0.17% | 86 |
|
|
2021
Q1 | $273K | Sell |
4,329
-739
| -15% | -$46K | 0.18% | 84 |
|
|
2020
Q4 | $314K | Sell |
5,068
-1,200
| -19% | -$73.8K | 0.23% | 73 |
|
|
2020
Q3 | $378K | Buy |
6,268
+430
| +7% | +$25.9K | 0.3% | 64 |
|
|
2020
Q2 | $343K | Sell |
5,838
-70
| -1% | -$4.19K | 0.3% | 63 |
|
|
2020
Q1 | $351K | Buy |
5,908
+19
| +0.3% | +$1.16K | 0.31% | 63 |
|
|
2019
Q4 | $397K | Buy |
5,889
+1,039
| +21% | +$59.5K | 0.34% | 68 |
|
|
2019
Q3 | $250K | Buy |
4,850
+300
| +7% | +$14.1K | 0.21% | 83 |
|
|
2019
Q2 | $206K | Sell |
4,550
-2,056
| -31% | -$95.8K | 0.18% | 93 |
|
|
2019
Q1 | $315K | Sell |
6,606
-120
| -2% | -$5.98K | 0.27% | 71 |
|
|
2018
Q4 | $350K | Hold |
6,726
| – | – | 0.32% | 57 |
|
|
2018
Q3 | $418K | Hold |
6,726
| – | – | 0.33% | 55 |
|
|
2018
Q2 | $372K | Buy |
6,726
+120
| +2% | +$6.48K | 0.3% | 57 |
|
|
2018
Q1 | $417K | Hold |
6,606
| – | – | 0.35% | 56 |
|
|
2017
Q4 | $405K | Sell |
6,606
-200
| -3% | -$12.5K | 0.34% | 48 |
|
|
2017
Q3 | $434K | Hold |
6,806
| – | – | 0.39% | 47 |
|
|
2017
Q2 | $379K | Hold |
6,806
| – | – | 0.36% | 53 |
|
|
2017
Q1 | $370K | Sell |
6,806
-200
| -3% | -$11K | 0.36% | 50 |
|
|
2016
Q4 | $409K | Buy |
7,006
+200
| +3% | +$10.9K | 0.39% | 48 |
|
|
2016
Q3 | $367K | Hold |
6,806
| – | – | 0.36% | 45 |
|
|
2016
Q2 | $501K | Hold |
6,806
| – | – | 0.48% | 49 |
|
|
2016
Q1 | $435K | Hold |
6,806
| – | – | 0.4% | 50 |
|
|
2015
Q4 | $468K | Sell |
6,806
-900
| -12% | -$59.5K | 0.46% | 48 |
|
|
2015
Q3 | $456K | Sell |
7,706
-303
| -4% | -$19.2K | 0.41% | 45 |
|
|
2015
Q2 | $533K | Hold |
8,009
| – | – | 0.5% | 38 |
|
|
2015
Q1 | $517K | Buy |
8,009
+2,000
| +33% | +$125K | 0.51% | 37 |
|
|
2014
Q4 | $355K | Buy |
+6,009
| New | +$339K | 0.33% | 43 |
|
Other funds holding BMY
Donald L. Hagan LLC's BMY Position: Q3 2025 in Review
Donald L. Hagan LLC opened a new position in Bristol-Myers Squibb (BMY) in Q3 2025: 20,550 shares worth $927K. The stake represents 0.46% of the portfolio and ranks #53 among its holdings. This is a return to the name: Donald L. Hagan LLC previously reported a position in BMY as recently as Q3 2023.
Donald L. Hagan LLC first reported a position in BMY in Q4 2014 and has held it in 37 quarters since. The position peaked at $1.85M in Q1 2023. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- Donald L. Hagan LLC held 20,550 shares of Bristol-Myers Squibb worth $927K as of Q3 2025.
- Bristol-Myers Squibb was a new Donald L. Hagan LLC position in Q3 2025.
- Bristol-Myers Squibb made up 0.46% of Donald L. Hagan LLC's portfolio in Q3 2025, its #53 holding.
- Donald L. Hagan LLC first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 37 quarters since.
- Donald L. Hagan LLC's Bristol-Myers Squibb position peaked at $1.85M in Q1 2023.
- 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on Donald L. Hagan LLC's 13F filing for Q3 2025, filed 16 Oct 2025.